Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension

Summary

The DigiCare4You project will use digital tools for early screening, prevention and management of type 2 diabetes (T2D) and hypertension (HTN). An implementation study will be conducted, targeting more than 10,000 families in two Middle Income Countries (Albania and Bulgaria) and two High Income Countries (Greece and Spain), considering vulnerable groups. Schools will be used as an entry point to the community. Building on an existing procedure for children's periodic growth assessment, conducted by school nurses or in collaboration with local community health centers, parents/ caregivers will be screened via a non-invasive self-reported digital screening tool. Those identified at high risk for T2D will be referred for glycaemia testing (fasting plasma glucose and glycated hemoglobin, HbA1c), as well as blood pressure (BP) measurements, at local community health centers. Parents/ caregivers confirmed to have pre-diabetes or diabetes (and possibly high BP) will be invited to join a mHealth self-management intervention coordinated by the community healthcare workforce. The goal of this intervention is to involve high-risk adults in the treatment process and decision-making on personalized behavioral goals (e.g. diet, physical activity, smoking, alcohol, medication compliance) that meet their needs, and ultimately improve the health status of parents/caregivers, as well as the lifestyle of the entire family.

Conditions

• Type 2 Diabetes
• PreDiabetes
• Hypertension

Interventions

BEHAVIORAL

mHealth intervention

Participants will receive mHealth intervention (mobile apps) and counseling sessions along with standard care

BEHAVIORAL

Standard care

Participants will receive standard care, including lifestyle recommendations.

Sponsors & Collaborators

• Medical University of Varna

  collaborator OTHER

• Centre for Research and Technology Hellas

  collaborator OTHER

• University of Medicine, Tirana

  collaborator OTHER

• La Trobe University

  collaborator OTHER

• National and Kapodistrian University of Athens

  collaborator OTHER

• NYU Langone Health

  collaborator OTHER

• University Ghent

  collaborator OTHER

• Universidad de Zaragoza

  collaborator OTHER

• PRIVANOVA SAS

  collaborator UNKNOWN

• Monash University

  collaborator OTHER

• METEDA SRL

  collaborator UNKNOWN

• Baker Heart and Diabetes Institute

  collaborator OTHER

• Sant'Anna School of Advanced Studies

  collaborator UNKNOWN

• International Diabetes Federation

  collaborator OTHER

• STICHTING INTERNATIONAL FOUNDATION FORINTEGRATED CARE

  collaborator UNKNOWN

• EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAMME (Project Number: 945246)

  collaborator UNKNOWN

• Harokopio University

  lead OTHER

Principal Investigators

• Yannis Manios, Professor · Harokopio University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2022-10-01

Primary Completion

2025-02-28

Completion

2025-02-28

Countries

• Albania
• Bulgaria
• Greece
• Spain

Study Locations